New Treatment Approved for Metastatic Small Cell Lung Cancer

2019-06-18T21:13:13+00:00June 18th, 2019|Hot Topics, News|

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for non-small cell lung cancer, this is the first approval of pembrolizumab for small cell lung cancer. This approval was based on two clinical trials, KEYNOTE-158 and KEYNOTE-028, which measured tumor [...]

Recent Advancements in Targeted Therapies

2019-03-07T16:19:27+00:00March 7th, 2019|Hot Topics|

The LCA Science and Research team just returned from the 2019 Targeted Therapies of Lung Cancer Meeting, and we have good news: treatment options continue to expand in the targeted therapies and immunotherapy space to treat all types of lung cancer. Here’s what we learned. All of the advancements presented emphasize the importance of molecular testing/biomarker testing so that the best treatments can be chosen for a patient’s unique cancer. There are currently approved targeted therapies for patients whose cancers [...]

2019 Forecast for Lung Cancer Research and Treatments

2019-01-24T16:10:01+00:00January 24th, 2019|Hot Topics|

Last year was an exciting year for lung cancer research with more U.S. Food and Drug Administration (FDA) approval decisions relevant to lung cancer than ever before.  So, what can we expect for 2019?  Another eventful year with researchers studying how to best give the approved drugs (i.e. what order and combinations) as well as expanding the options with more types of therapies. IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER First, there is the rapidly growing field of immunotherapy.  We have [...]

4 Simple Steps to Finding the Right Clinical Trial

2018-11-29T18:27:09+00:00November 28th, 2018|Hot Topics, News|

Today, there are more options for lung cancer treatment than ever before. Some are already approved and available. Others are only available through clinical trials. With so many clinical trials out there, the process of finding one can seem daunting. Not to worry! We have you covered. Here are four steps to finding the right clinical trial for you. 1) GATHER INFORMATION: Each clinical trial is looking for a very specific patient and has a number of criteria that you [...]

LCA’s Research Showcased on a World Stage

2018-10-04T13:38:47+00:00September 18th, 2018|Hot Topics, News|

The Lung Cancer Alliance team is heading to IASLC's World Conference on Lung Cancer (WCLC), Toronto, Canada from September 23-28, 2018 and will be presenting on hot topics in the field of lung cancer including: clinical trials, long-term survivorship, stigma, advocacy and much more! Below are details on our whereabouts and what we will be discussing.  If you are in Toronto, stop by! For news and updates live from the event, follow us on Twitter at @LCAorg or via the event [...]

Science & Research Advances in 2017

2018-03-21T20:37:45+00:00December 14th, 2017|Hot Topics, News|

By Jennifer C. King, PhD, Director of Science & Research at Lung Cancer Alliance Research on the treatment of lung cancer has been moving quickly and 2017 was no different. Precision medicine was a key theme this year - there have been many treatment advances that depend on the gene changes in each person’s lung cancer. Approvals of New Drugs and Molecular Tests The United States Food and Drug Administration (FDA) has approved brand new drugs for non-small cell lung [...]